Hurstville, Australia

Retina and Eye Consultants

Atrophy

Macular Degeneration

Geographic Atrophy

Macular Edema

Edema

Retinal Vein Occlusion

Neoplasm Metastasis

APL-2

Faricimab

Dexamethasone

Pegcetacoplan

IBE-814

Apellis Pharmaceuticals

McMaster University

Ripple Therapeutics

condition

allSponsorName

Roche

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.

Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Retina and Eye Consultants | Hurstville, Australia

Site insights

Work at this site?

Active trials

Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial (INSITE-DME)

Trial sponsors